Acivir DT 400 mg Cipla

What Is Acivir DT 400 mg? Acivir DT 400 mg is a synthetic purine nucleoside analogue antiviral formulation manufactured by Cipla, supplied as dispersible tablets for laboratory and in-vitro research applications. Each tablet contains acyclovir as the active pharmaceutical ingredient — a compound widely employed as a reference standard in virology research. Acyclovir is of significant interest to researchers investigating the selective inhibition of viral DNA polymerase enzymes, particularly those seeking to examine the mechanistic steps by which nucleoside analogues interfere with herpesvirus replication cycles in controlled experimental settings. Visitors exploring our broader catalogue at uksteroidshops.co.uk will find Acivir DT 400 mg listed alongside a curated selection of verified research compounds. Research Applications and Investigative Context In preclinical and in-vitro research models, acyclovir undergoes intracellular phosphorylation to its active triphosphate form, which subsequently competes with deoxyguanosine triphosphate for incorporation into viral DNA chains. Once incorporated, it acts as a chain terminator, halting viral DNA synthesis. Researchers investigating herpes simplex virus (HSV-1, HSV-2), varicella-zoster virus (VZV), and Epstein-Barr virus (EBV) polymerase activity frequently evaluate acyclovir analogues as mechanistic probes in cell culture assays. The dispersible tablet formulation from Cipla allows for straightforward solubilisation, facilitating consistent stock preparation in aqueous research media. Teams evaluating antiviral selectivity indices and therapeutic windows find the 400 mg unit dose a practical working concentration for serial dilution protocols. Browse our Acyclovir research compounds to explore related antiviral reference materials available from our UK stock. Product Specifications Acivir DT 400 mg — Technical Specification Summary Parameter Detail Active Ingredient Acyclovir (Aciclovir) Formulation Dispersible Tablets Strength per Tablet 400 mg Manufacturer Cipla CAS Number 59277-89-3 Molecular Formula C₈H₁₁N₅O₃ Molecular Weight 225.21 g/mol Storage Room temperature, dry, away from direct light Research Use In-vitro viral DNA polymerase inhibition studies Researchers sourcing reference-grade antiviral compounds may also find value in reviewing our oral steroid research compounds and our range of injectable steroids for research, both of which complement broader pharmacological investigations into receptor modulation and metabolic pathways. Compliance and Responsible Research Acivir DT 400 mg by Cipla is supplied strictly for legitimate in-vitro and laboratory research purposes. This product is not intended for human consumption, self-medication, or therapeutic use outside of a licensed clinical setting. All purchases must comply with applicable UK and local regulations. Research use should be conducted by qualified personnel in an appropriate laboratory environment. This product information does not constitute medical advice. You must be 18 years of age or older to purchase. Always verify legal status in your jurisdiction before ordering.